Plasma levels of B-type natriuretic peptide in patients with unstable angina pectoris or acute myocardial infarction: Prognostic significance and therapeutic implications

Angiology

Volumn 58, Issue 3, 2007, Pages 269-274

  Ahmed, Waqas ^a   Zafar, Saman ^a   Alam, Ali Y ^a   Ahktar, Naveed ^a   Shah, Mumtaz A ^a   Alpert, Martin A ^b  

^a SHIFA INTERNATIONAL HOSPITAL   (Pakistan)

^b ST JOHN S MERCY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; ST SEGMENT ELEVATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CARDIAC OUTPUT, LOW; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; TROPONIN T;

EID: 34250705324     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707302543     Document Type: Article

References (20)

1. Jernberg T., James S., Lindhal B.,, et al. Natriuretic peptides in unstable coronary artery disease. Eur Heart J 25: 1486-1493, 2004.
2. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 339: 321-328, 1998.
3. Breathing Not Properly Multinational Study Investigators: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347: 161-167, 2002.
4. Morrow DA, de Lemos JA, Sabatine MS,, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 41: 1264-1272, 2003.
5. de Lemos JA, Morrow DA, Bentley JH,, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345: 1014-1012, 2001.
6. Mega JL, Morrow DA, de Lemos JA,, et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: An ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 44: 335-339, 2004.
7. Jiang CY, Li N., Wang JA: Use of B-type natriuretic peptide in evaluation of early percutaneous coronary intervention in patients with acute coronary syndrome. Chin Med J 117: 1130-1134, 2004.
8. Omland T., Aakvaag A., Bonarjee VV,, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93: 1963-1969, 1996.
9. Morita E., Yasue H., Yoshimura M.,, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88: 82-91, 1993.
10. Richards AM, Nicholls MG, Espiner EA,, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107: 2786-2792, 2003.
11. Darbar D., Davidson NC, Gillepsie N.,, et al. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol 78: 284-287, 1996.
12. Sadanandan S., Cannon CP, Chekuri K.,, et al. Association with elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 44: 564-568, 2004.
13. Arakawa N., Nakamura M., Aoki H.,, et al. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 27: 1656-1661, 1996.
14. Antman EM, Anbe DT, Armstrong PW,, et al. ACC/ AHA Guidelines for the management of patients with ST elevation myocardial infarction. J Am Coll Cardiol 44: 671-719, 2004.
15. Antman EM, Beasley JW, Califf RM,, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST segment myocardial infarction. An executive summary. J Am Coll Cardiol 40: 1366-1374, 2002.
16. McKee PA, Castelli WP, McNamara PM,, et al. The natural history of congestive heart failure. The Framingham Study. N Engl J Med 285: 1441-1446, 1971.
17. Popma JJ, Hartzell VS, Williams DO: ACC/AHA guidelines for percutaneous coronary intervention. J Am Coll Cardiol 37: 2239-2260, 2001.
18. Tateishi J., Masutani M., Ohyanagi M.,, et al. Transient increase in plasma brain natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 23: 776-780, 2000.
19. Marumoto K., Hamada M., Hiwada K.: Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischemia induced by dynamic exercise in patients with angina pectoris. Clin Sci 88: 551-556, 1995.
20. Jernberg T., Lindahl B., Siegbahn A.,, et al. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary disease. J Am Coll Cardiol 42: 1909-1916, 2003.